SEC Comment Letter for ABBOTT LABORATORIES (ABT) — Jun 30, 2017
ABBOTT LABORATORIES
Date: June 30, 2017 · CIK: 0000001800 · Accession: 0000000000-17-023015
AI Filing Summary & Sentiment
Letter
June 30, 2017 Brian B. Yoor SVP, Finance and Chief Financial Officer Abbott Laboratories 100 Abbott Park Road Abbott Park, IL 60064 Abbott Laboratories Form 8-K filed January 25, 2017 File No. 001-02189Re: Dear Mr. Yoor: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence by the staff. Division of Corporation Finance Office of Healthcare and Insurance
Show Raw Text
June 30, 2017
Brian B. Yoor
SVP, Finance and Chief Financial Officer
Abbott Laboratories
100 Abbott Park Road
Abbott Park, IL 60064
Abbott Laboratories
Form 8-K filed January 25, 2017
File No. 001-02189Re:
Dear Mr. Yoor:
We have completed our review of your filing. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence by the staff.
Division of Corporation Finance
Office of Healthcare and
Insurance